News | December 17, 2024
Merck to acquire HUB Organoids to advance cell culture portfolio
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
The Board also decided that Auro Vaccines will explore the possibilities of offering contract manufacturing to global vaccine developers
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The company uses iPS cells to develop treatments for diseases relating to the kidney
Subscribe To Our Newsletter & Stay Updated
